CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 62 enrolled
Drug / intervention
hyaluronic acid geldevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01176773
NCT01176773N/ACompleted

Safety and Effectiveness of Juvéderm® Ultra Lip Injectable Gel for Lip Enhancement

Allergan Medical·interventional·Posted Aug 6, 2010·Updated Oct 13, 2014

In Brief

A clinical study evaluating hyaluronic acid gel for Lip Enhancement. Completed, enrolled 62 participants across 4 sites.

Detailed Summary

The purpose of this study is to demonstrate the safety and effectiveness of Juvéderm® Ultra Lip Injectable Gel for lip enhancement.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLip Enhancement
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedAug 6, 2010
Enrollment StartAug 1, 2010
Primary CompletionMay 1, 2011
Study CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 15.9 years ago

Interventions

hyaluronic acid geldevice

Dosage per Investigator's discretion to obtain lip treatment goal; 1 touch-up treatment is allowed 14 days after initial treatment. Maximum total volume per subject is 2.0 mL